A single dose of three tablets. No hospital stay. Free to patients. After two decades of collaborative research across Africa and Europe, DNDi and Sanofi have developed a new oral treatment for sleeping sickness that has cleared a major regulatory hurdle. The WHO’s 2030 elimination target now looks achievable.
Ms. Robbins shares her challenging journey with cutaneous leishmaniasis, from misdiagnosis to founding the Leishmaniasis Advocacy Network. This interview from DNDi highlights urgent needs for awareness, affordable treatment, and patient-centered care.
Guinea has achieved a historic milestone by eliminating sleeping sickness as a public health problem, becoming the first country to conquer this deadly neglected tropical disease with the support of DNDi. In Step 4, read about going the last mile.
Guinea has achieved a historic milestone by eliminating sleeping sickness as a public health problem, becoming the first country to conquer this deadly neglected tropical disease with the support of DNDi. In Step 3, read how going door to door helped the process.
Guinea has achieved a historic milestone by eliminating sleeping sickness as a public health problem, becoming the first country to conquer this deadly neglected tropical disease with the support of DNDi. In Step 2, read how community trust was built.